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Discussion
Dr Frank L. Hanley (Stanford, Calif). Dr Ananiadou, you and your
colleagues have designed and executed an excellent study that con-
vincingly shows in this particular porcine model that increased levels
of hypothermia from 18°C down to 10°C during 75 minutes of HCA
results in less DNA fragmentation and greater expression of the
anti-apoptotic protein Bcl-2 in the vulnerable neocortex and hip-
pocampus.
The results of this nicely designed study stand on their own. They
are very clear and I would have no argument with what you have
shown. However, when it comes to the suggested mechanism and
causality that you have implied, there is a little less clarity. That is
where I would like to focus just one comment and question and see
what you think about it.
You have stated very specifically that reduced temperature acti-
vates Bcl-2, implying a proposed specific protective effect of lower
temperature itself. This would obviously have extremely important
implications for how we manage patients clinically and in patients in
whom deep HCA is used. However, is it really the lower temperature
that activates this anti-apoptotic mechanism or is it simply that the
lower temperature reduces the overall ischemic insult and it is this
lesser ischemic insult itself that allows for the increased Bcl-2 activ-
ity? Clearly, the ischemic insult is related to two things, the length of
circulatory arrest and the temperature at which that length of circu-
latory arrest exists. The combination of the length and the temperature
define the ischemic insult in rough terms.
What I am really asking is, have you looked at this in another way?
Would an insult of less length of circulatory arrest, say 50 minutes
rather than 75, with a temperature of only 18°C result in increased
Bcl-2 activity? Or alternatively, if you increased the ischemic time,
the circulatory arrest time to, say, 90 minutes at 10°C, would that not
increase Bcl-2 activity, getting more to the mechanism of what
actually is increasing your protective anti-apoptotic protein expres-
sion?
Dr Ananiadou. What has changed in this protocol, in the two
groups, is not the duration of ischemia; it is only the temperature. That
is why we hypothesize that the lower temperature is the mechanism
that causes increased Bcl-2 immunoreactivity. It is the only parameter
to change in this model. The arrest time is the same, 75 minutes. Thus
the ischemic interval is the same. The ischemic insult is the same. The
protective mechanism that induces the increase of Bcl-2 immunore-
activity is the lowering temperature. That is what I think.
Dr Hanley. I understand. But I think there is a fine point here that
is very, very important. The ischemic insult is the same, 75 minutes,
there is no question, but the injury induced by an ischemic insult may
be very different at different temperatures. It is the injury to the neuron
that is critical here.
If you are arguing that temperature in and of itself directly,
mechanistically increases Bcl-2, then if we are going to do a circula-
tory arrest operation and have only 20 minutes of circulatory arrest, it
would mean we should go down to 10°C. However, if we might need
to do circulatory arrest for 40 or 50 or 60 minutes, knowing whether
going down to 10°C is more important in that setting than in the
shorter setting is critical to how we would manage our patients.
You are implying that the temperature of 10°C in and of itself is
always going to be helpful, whereas I am saying it does not seem that
clear to me from your model that that is actually the case. Rather, it
is the level of neuroinjury that is a combination of arrest time and the
lower temperature that may well be what is important.
Dr Ananiadou. It is believed that hypothermia alters the pattern of
sensitivity of cells. That is why we have different damage. But, on the
whole, I agree with you; profound hypothermia is not the only
parameter.
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